showed a trendP = 0.069
In long-term follow-up (up to 20 years), “C-peptide negative” patients had significantly improved survival ( P = 0.019); “C-peptide positive” recipients showed a trend to better survival ( P = 0.069).
In long-term follow-up (up to 20 years), “C-peptide negative” patients had significantly improved survival ( P = 0.019); “C-peptide positive” recipients showed a trend to better survival ( P = 0.069).